Innovative Eyewear Inc short interest in 2022

In 2022, Innovative Eyewear Inc's disclosed short interest ran from 1.19% of shares outstanding on 30 Sep 2022 to 1.09% on 15 Dec 2022, a change of -0.10 percentage points. The year's high was 2.55% on 14 Oct 2022 and its low 0.75% on 30 Nov 2022, averaging 1.35% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.79 days on 15 Dec 2022. Full history: Innovative Eyewear Inc.

Cite this page

Plain

Short position data for Innovative Eyewear Inc short interest in 2022: FINRA, compiled by howshorted.com, settlement date 15 Dec 2022. https://howshorted.com/us/company/lucyw/2022/

Wikipedia

<ref>{{cite web |title=Innovative Eyewear Inc short interest in 2022 short position data |url=https://howshorted.com/us/company/lucyw/2022/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2022-12-15 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-innovative-eyewear-inc-short-interest-in-2022-12-15,
  title        = {Innovative Eyewear Inc short interest in 2022 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/lucyw/2022/}},
  note         = {Data: FINRA, settlement date 15 Dec 2022; accessed 2026-10-13},
  year         = {2022}
}

By year: 2022 · 2023 · 2024 · 2025 · 2026

2022 in figures

Start of year: 1.19% (30 Sep 2022)
End of year: 1.09% (15 Dec 2022)
Change: -0.10 pp
High: 2.55% (14 Oct 2022)
Low: 0.75% (30 Nov 2022)
Average: 1.35%
Highest days to cover: 2.79 (15 Dec 2022)

Every report in 2022

Innovative Eyewear Inc short interest in 2022
Settlement	Short interest	Days to cover
30 Sep 2022	1.19%	2.05
14 Oct 2022	2.55%	1.00
31 Oct 2022	1.28%	1.00
15 Nov 2022	1.22%	1.71
30 Nov 2022	0.75%	2.23
15 Dec 2022	1.09%	2.79

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.